ADVA Biotechnology
Automated Platform for Autologous Cell Manufacturing
StartupADVA Biotechnology is a פארק תעשיות בר-לב-based startup in the Health Tech & Life Sciences sector, established in 2016. Automated Platform for Autologous Cell Manufacturing. The company has raised a total of $385K across 3 funding rounds, currently at the Seed stage. ADVA Biotechnology was founded by Tal Slonim, Ron Elazary-Vulcani, Barbara Paldus, Ohad Karnieli. Key investors include AGP Ventures, ExitValley. The company has 11-50 employees. Core technologies: Biologicals, Cells.
With $385K in total funding, ADVA Biotechnology is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released.
- StageSeed
- ProductReleased
- ModelB2B
- Employees11-50
- HQפארק תעשיות בר-לב
- Last Round$385K
- AGP Ventures
- ExitValley
Tal SlonimCo-founder & Board Member
Ron Elazary-VulcaniCo-founder & Board Member
Barbara PaldusCo-founder & Board Member
Ohad KarnieliFounder & CEO
4 articles covered by sources including www.companyinsight.co.uk,
www.jpost.com,
www.globenewswire.com.
What does ADVA Biotechnology do?
ADVA Biotechnology develops enabling technologies for cell therapy manufacturing. The company has developed ADVA X3, a robust, modular cell-manufacturing cGMP system based on a single-use end-to-end solution. ADVA X3 enables autologous cell therapy manufacturing at the bedside, allowing optimization, tight quality assurance, improved availability, reduced time to market, and significant cost reduction. The automated platform is designed to enable autologous manufacturing of additional types of cells with a change in the disposable chamber, allowing efficiency and flexibility with a long pipeline of products.
How much funding has ADVA Biotechnology raised?
ADVA Biotechnology has raised $385K in total funding across 3 rounds. The company is currently at the Seed stage. Key investors include AGP Ventures, ExitValley.
Who founded ADVA Biotechnology?
ADVA Biotechnology was founded in 2016 by Tal Slonim (Co-founder & Board Member), Ron Elazary-Vulcani (Co-founder & Board Member), Barbara Paldus (Co-founder & Board Member), Ohad Karnieli (Founder & CEO).
What sector is ADVA Biotechnology in?
ADVA Biotechnology operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Life Sciences, Pharmaceuticals.
Where is ADVA Biotechnology located?
ADVA Biotechnology is based in Bar Lev Industrials Park, Israel.